Synbiotic therapy reduces the pathological gram-negative rods caused by an increased acetic acid concentration in the gut

Digestive Diseases and Sciences

Volumn 57, Issue 10, 2012, Pages 2642-2649

  Hayakawa, Mineji ^a   Asahara, Takashi ^b   Ishitani, Toshiteru ^c   Okamura, Atsushi ^c   Nomoto, Koji ^b   Gando, Satoshi ^a  

^a HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^c Heiseikai Inoue Hospital   (Japan)

Author keywords

Critical illness; Enteral nutrition; Probiotics; Pseudomonas; Ventilator associated pneumonia

Indexed keywords

ACETIC ACID; GALACTOSE OLIGOSACCHARIDE; SYNBIOTIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTERIC FEEDING; FEMALE; HUMAN; LACTOBACILLUS BIFIDUS; LOWER RESPIRATORY TRACT INFECTION; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STOMACH PH; SYNBIOTIC THERAPY; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA;

ACETIC ACID; AGED; AGED, 80 AND OVER; BIFIDOBACTERIUM; FEMALE; GASTROINTESTINAL TRACT; GRAM-NEGATIVE BACTERIA; HUMANS; HYDROGEN-ION CONCENTRATION; LACTOBACILLUS; MALE; MIDDLE AGED; OLIGOSACCHARIDES; SYNBIOTICS;

EID: 84867861469     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2201-9     Document Type: Article

References (33)

1. Rayes N, Seehofer D, Theruvath T, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized, double-blind trial. Am J Transpl. 2005;5:125-130.
2. Rayes N, Seehofer D, Hansen S, et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation. 2002;74:123-127.
3. Rayes N, Hansen S, Seehofer D, et al. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition. 2002; 18:609-615.
4. Kanazawa H, Nagino M, Kamiya S, et al. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg. 2005;390:104-113.
5. Sugawara G, Nagino M, Nishio H, et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006;244:706-714.
6. Olah A, Belagyi T, Poto L, Romics L Jr, Bengmark S. Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study. Hepatogastroenterology. 2007;54:590-594.
7. Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg. 2002;89:1103-1107.
8. Besselink MG, van Santvoort HC, Buskens E, Boermeester M, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:651-659.
9. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E. Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial. World J Surg. 2006;30: 1848-1855.
10. Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J Parenter Enteral Nutr. 2007;31:119-126.
11. McNaught CE, Woodcock NP, Anderson AD, MacFie J. A prospective randomised trial of probiotics in critically ill patients. Clin Nutr. 2005;24:211-219.
12. Jain PK, McNaught CE, Anderson AD, Mac Fie J, Mitchell CJ. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr. 2004;23:467-475.
13. Shimizu K, Ogura H, Goto M, et al. Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report. Dig Dis Sci. 2009;54:1071-1078.
14. Klarin B, Johansson ML, Molin G, Larsson A, Jeppsson B. Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Crit Care. 2005;9:R285-R293.
15. Forestier C, Guelon D, Cluytens V, et al. Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Crit Care. 2008;12:R69.
16. Knight DJ, Gardiner D, Banks A, et al. Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Med. 2009;35:854-861.
17. National Nasocomial infections Surveillance (NNIS). System Report data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470-485.
18. Chastere J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867-903.
19. Matsuda K, Tsuji H, Asahara T, Kado Y, Nomoto K. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environ Microbiol. 2007;73: 32-39.
20. Matsuda K, Tsuji H, Asahara T, et al. Establishment of an analytical system for the human fecal microbiota, based on reverse transcription- quantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol. 2009;75:1961-1969.
21. Fujimoto J, Matsuki T, Sasamoto M, Tomii Y, Watanabe K. Identification and quantification of Lactobacillus casei strain Shirota in human feces with strain-specific primers derived from randomly amplified polymorphic DNA. Int J Food Microbiol. 2008;126:210-215.
22. Kikuchi H, Yajima T. Correlation between water-holding capacity of different types of cellulose in vitro and gastrointestinal retention time in vivo of rats. J Sci Food Agric. 1992; 60:139-146.
23. Matsumoto K, Takada T, Shimizu K, et al. The effects of a probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microflora of sub-optimal health state volunteers: a randomized placebocontrolled cross-over study. Biosci Microflora. 2006;25:39-48.
24. Matsumoto K, Takada T, Shimizu K, et al. Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stools. J Biosci Bioeng. 2010;110:547-552.
25. Amaretti A, Bernardi T, Tamburini E, et al. Kinetics and metabolism of Bifidobacterium adolescentis MB 239 growing on glucose, galactose, lactose, and galactooligosaccharides. Appl Environ Microbiol. 2007;73:3637-3644.
26. De Vries W, Gerbrandy SJ, Stouthamer AH. Carbohydrate metabolism in Bifidobacterium bifidum. Biochim Biophys Acta. 1967;136:415-425.
27. Eklund T. The antimicrobial effect of dissociated and undissociated sorbic acid at different pH levels. J Appl Bacteriol. 1983; 54:383-389.
28. Ostling CE, Lindgren SE. Inhibition of enterobacteria and Listeria growth by lactic, acetic and formic acids. J Appl Bacteriol. 1993;75:18-24.
29. Deibel RH, Niven CF Jr. Pyruvate fermentation by Streptococcus faecalis. J Bacteriol. 1964;88:4-10.
30. Isakow W, Morrow LE, Kollef MH. Probiotics for preventing and treating nosocomial infections: review of current evidence and recommendations. Chest. 2007;132:286-294.
31. McNabb B, Isakow W. Probiotics for the prevention of nosocomial pneumonia: current evidence and opinions. Curr Opin Pulm Med. 2008;14:168-175.
32. Siempos II, Ntaidou TK, Falagas ME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med. 2010;38:954-962.
33. Snydman DR. The safety of probiotics. Clin Infect Dis. 2008;46: S104-S111.